171 related articles for article (PubMed ID: 30339962)
21. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
22. Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies.
Donaghy PC; Firbank MJ; Thomas AJ; Lloyd J; Petrides G; Barnett N; Olsen K; O'Brien JT
Mov Disord; 2018 Jul; 33(7):1130-1138. PubMed ID: 29672930
[TBL] [Abstract][Full Text] [Related]
23. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
Iizuka T; Kameyama M
Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
[TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
Fodero-Tavoletti MT; Smith DP; McLean CA; Adlard PA; Barnham KJ; Foster LE; Leone L; Perez K; Cortés M; Culvenor JG; Li QX; Laughton KM; Rowe CC; Masters CL; Cappai R; Villemagne VL
J Neurosci; 2007 Sep; 27(39):10365-71. PubMed ID: 17898208
[TBL] [Abstract][Full Text] [Related]
25. Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies.
Chow N; Aarsland D; Honarpisheh H; Beyer MK; Somme JH; Elashoff D; Rongve A; Tysnes OB; Thompson PM; Apostolova LG
Dement Geriatr Cogn Disord; 2012; 34(1):44-50. PubMed ID: 22922563
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
Gupta HV; Beach TG; Mehta SH; Shill HA; Driver-Dunckley E; Sabbagh MN; Belden CM; Liebsack C; Dugger BN; Serrano GE; Sue LI; Siderowf A; Pontecorvo MJ; Mintun MA; Joshi AD; Adler CH
J Alzheimers Dis; 2021; 80(4):1603-1612. PubMed ID: 33720879
[TBL] [Abstract][Full Text] [Related]
27. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
Kasanuki K; Iseki E; Fujishiro H; Yamamoto R; Higashi S; Minegishi M; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H
J Neurol Sci; 2012 Mar; 314(1-2):111-9. PubMed ID: 22041339
[TBL] [Abstract][Full Text] [Related]
28. A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium.
Oppedal K; Ferreira D; Cavallin L; Lemstra AW; Ten Kate M; Padovani A; Rektorova I; Bonanni L; Wahlund LO; Engedal K; Nobili F; Kramberger M; Taylor JP; Hort J; Snædal J; Blanc F; Walker Z; Antonini A; Westman E; Aarsland D;
Alzheimers Dement; 2019 Mar; 15(3):400-409. PubMed ID: 30439333
[TBL] [Abstract][Full Text] [Related]
29. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
30. Laminar distribution of beta-amyloid deposits in dementia with Lewy bodies and in Alzheimer's disease.
Armstrong RA
Am J Alzheimers Dis Other Demen; 2006; 21(3):175-81. PubMed ID: 16869338
[TBL] [Abstract][Full Text] [Related]
31. Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment.
Kantarci K; Lesnick T; Ferman TJ; Przybelski SA; Boeve BF; Smith GE; Kremers WK; Knopman DS; Jack CR; Petersen RC
Neurology; 2016 Nov; 87(22):2317-2323. PubMed ID: 27807186
[TBL] [Abstract][Full Text] [Related]
32. Imaging beta-amyloid burden in aging and dementia.
Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
[TBL] [Abstract][Full Text] [Related]
33. Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes.
Kalaitzakis ME; Walls AJ; Pearce RK; Gentleman SM
Neurobiol Dis; 2011 Feb; 41(2):377-84. PubMed ID: 20951207
[TBL] [Abstract][Full Text] [Related]
34. Cholinergic dysfunction, neurodegeneration, and amyloid-beta pathology in neurodegenerative diseases.
Petrova T; Orellana C; Jelic V; Oeksengaard AR; Snaedal J; Høgh P; Andersen BB; Naik M; Engedal K; Wahlund LO; Ferreira D
Psychiatry Res Neuroimaging; 2020 Aug; 302():111099. PubMed ID: 32505903
[TBL] [Abstract][Full Text] [Related]
35. The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies.
Abdelnour C; Ferreira D; Oppedal K; Cavallin L; Bousiges O; Wahlund LO; Hort J; Nedelska Z; Padovani A; Pilotto A; Bonanni L; Kramberger MG; Boada M; Westman E; Pagonabarraga J; Kulisevsky J; Blanc F; Aarsland D
Neuroimage Clin; 2020; 27():102333. PubMed ID: 32674011
[TBL] [Abstract][Full Text] [Related]
36. Alteration of medial temporal lobe metabolism related to Alzheimer's disease and dementia with lewy bodies.
Kang S; Jeon S; Lee YG; Ye BS
Alzheimers Res Ther; 2024 Apr; 16(1):89. PubMed ID: 38654300
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
Ye BS; Lee S; Yoo H; Chung SJ; Lee YH; Choi Y; Lee PH; Sohn YH; Yun M
Neurobiol Aging; 2020 Mar; 87():11-17. PubMed ID: 31791660
[TBL] [Abstract][Full Text] [Related]
38. Clinical and striatal dopamine transporter predictors of β-amyloid in dementia with Lewy bodies.
Yoo HS; Lee S; Chung SJ; Lee YH; Ye BS; Sohn YH; Yun M; Lee PH
Neurology; 2020 Mar; 94(13):e1344-e1352. PubMed ID: 32086384
[TBL] [Abstract][Full Text] [Related]
39. Differentiating Dementia with Lewy Bodies and Alzheimer's Disease by Deep Learning to Structural MRI.
Nemoto K; Sakaguchi H; Kasai W; Hotta M; Kamei R; Noguchi T; Minamimoto R; Arai T; Asada T
J Neuroimaging; 2021 May; 31(3):579-587. PubMed ID: 33476487
[TBL] [Abstract][Full Text] [Related]
40. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.
Burton EJ; Barber R; Mukaetova-Ladinska EB; Robson J; Perry RH; Jaros E; Kalaria RN; O'Brien JT
Brain; 2009 Jan; 132(Pt 1):195-203. PubMed ID: 19022858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
